[Clinical early phase II study of bicalutamide (Casodex) in patients with prostatic cancer].
Kotake T, Usami M, Isaka S, Shimazaki J, Nakano E, Okuyama A, Okajima E, Kanetake H, Saitoh Y, Kumamoto Y, Orikasa S, Sakata Y, Hosaka M, Akaza H, Koiso K, Honma Y, Aso Y, Oishi K, Yoshida O, Naitoh S, Kumazawa J, Koyanagi T, Yachiku S, Shiraiwa Y, Tsukagoshi S.
Kotake T, et al.
Hinyokika Kiyo. 1996 Feb;42(2):157-68.
Hinyokika Kiyo. 1996.
PMID: 8712092
Clinical Trial.
Japanese.